PUBBLICAZIONI SCIENTIFICHE
I risultati delle ricerche finanziate dalla Associazione in questi anni sono stati presentati
in numerosi convegni e congressi nazionali ed internazionali e pubblicati su importanti riviste scientifiche.
IMPACT FACTOR
L'impact factor dei lavori scientifici è attualmente di 2143,60 punti considerando l'I.F. più recente della rivista
- Pubblicazione:
- Journal Clinical of Oncology 27:27-:4555:4562, 2009 - I.F. 44,54
- AUTORI: Massimo Federico, Monica Bellei, Luigi Marcheselli, Stefano Luminari, Armando Lopez-Guillermo, Philippe Solal-Céligny et al.
Purpose The aim of the F2 study was to verify whether a prospective collection of data would enable the development of a more accurate
- Pubblicazione:
- Clinical Lymphoma and Myeloma (ISSN 2152-2650), 9:2-138:144, 2009 - I.F. 2,38
- AUTORI: Iannitto E., Minardi V., Gobbi P.G., Calvaruso G., Tripodo C., Marcheselli L., Luminari S., Merli F., Baldini L., Stelitano C., Callea V., Petrini M., Angrilli F., Quarta G., Vallisa D., Molica S., Liardo E., Polimeno G., Brugiatelli M., Federico M.
Abstract: Purpose: In the pre-positron emission tomography era, the Gruppo Italiano Studio Linfomi (GISL) investigated the feasibility and efficacy of a treatment based on
- Pubblicazione:
- Journal Clinical of Oncology 27:5-805:811, 2009 - I.F. 44,54
- AUTORI: Federico M., Luminari S., Iannitto E., Polimeno G., Marcheselli L., Gobbi PG. et al.
Purpose To compare doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) versus bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPP) versus cyclophosphamide, lomustine, vindesine, melphalan, prednisone,
- Pubblicazione:
- Haematologica 94:1-146:148, 2009 - I.F. 9,94
- AUTORI: Carella AM., Bellei M., Brice P., Gisselbrecht C., Visani G., Federico M. et al.
No abstract available
- Pubblicazione:
- Journal of Proteome Research 8:11- 4916:4933, 2009 - I.F. 4,46
- AUTORI: Laura Cortesi, Andrea Barchetti, Elisabetta De Matteis, Elena Rossi, Lara Della Casa, Anna Iannone et al.
An attempt for the identification of potential biomarkers predictive of response to chemotherapy (CHT) in breast cancer patients has been performed by the use
- Pubblicazione:
- Haematologica 93:9-1335:1342, 2008 - I.F. 9,94
- AUTORI: Sacchi S., Marcheselli L., Bari A . Marcheselli R., Pozzi S., Brugiatelli M., et al.
Background Improved treatment has increased the life expectancy of patients with non-Hodgkin’s lymphoma, but few studies have addressed the issue of second cancer in
- Pubblicazione:
- Leukemia & Lymphoma 49:7-1374:1383, 2008 - I.F. 3,28
- AUTORI: Neri A., Marmiroli S., Tassone P., Lombardi L., Nobili L., Sacchi S., et al.
Deregulation of the protein kinase C (PKC) signalling pathway has been implicated in tumor progression. Here we investigated the PKC inhibitor enzastaurin for its
- Pubblicazione:
- Haematologica 93:3-398:404, 2008 - I.F. 9,94
- AUTORI: Sacchi S., Marcheselli L., Bari A . Marcheselli R., Pozzi S., Brugiatelli M., et al.
Background Relatively little information is available on the incidence of secondary cancer in non-Hodgkin’s lymphoma. The aim of this long-term follow-up study was to
- Pubblicazione:
- Hematologicsal Oncology 25:4-189:197, 2007 - I.F. 5,27
- AUTORI: Luminari S., Cesaretti M., Rashid I., Mammi C., Montanini A., Federico M., et al
We conducted a population-based study of peripheral lymphomas (PL) that had been diagnosed between 1997 and 2003 in the province of Modena, Italy, with
- Pubblicazione:
- BMC Cancer 7-230, 2007 - I.F. 4,06
- AUTORI: Mucciarini C., Rossi G., Bertolini F., Valli R., Cirilli C., Federico M., et al.
Background: Although the diagnostic criteria and pathogenesis of gastrointestinal stromal tumors (GIST) have recently been elucidated, knowledge of the epidemiology of this malignancy is
- Pubblicazione:
- Haematologica 92:11-1482:1488, 2007 - I.F. 9,94
- AUTORI: Federico M., Guglielmi C., Luminari S., Mammi C., Marcheselli L., Brugiatelli M., et al.
Background and Objectives Although serum β2 microglobulin (β2M) is an easy parameter to measure, and overexpressed in a large number of lymphoproliferative diseases, its
- Pubblicazione:
- Cancer 110:1-121:128, 2007 - I.F. 6,10
- AUTORI: Sacchi S., Pozzi S., Marcheselli R., Federico M., Tucci A., Brugiatelli M., et al.
BACKGROUND. The current study was conducted to asses the safety profile and clinical activity of rituximab in combination with fludarabine and cyclophosphamide in patients
- Pubblicazione:
- Cancer 109:10-2077:2082, 2007 - I.F. 6,10
- AUTORI: Sacchi S., Pozzi S., Marcheselli L., Bari A., Luminari S., Brugiatelli M., et al.
BACKGROUND. It is unclear whether new treatment modalities have improved the survival of follicular lymphoma patients. Some data show that there has been no
- Pubblicazione:
- Leukemia & Lymphoma 48:2-367:373, 2008 - I.F. 3,28
- AUTORI: Merli F., Bertini M., Luminari S., Mozzana R., Botto B., Liberati A.M., Baldini L., Cabras G., Di Vito F., Orsucci L., Naglieri E., Polimeno G., Marcheselli L., Pennese E., Vitolo U., Federico M., Gallo E.
The Intergruppo Italiano Linfomi started, in 1996, a randomized trial for the initial treatment of elderly patients (older than 65 years) with Diffuse Large
- Pubblicazione:
- Leukemia & Lymphoma 48:1-56:64, 2007 - I.F. 3,28
- AUTORI: Pozzi S., Marcheselli R., Sacchi S., Baldini L., Angrilli F., Pennese E., et al.
Over a period of 28 months, we observed five cases of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates (BP) at
- Pubblicazione:
- International JOurnao of Cancer 120:2-392:397, 2007 - I.F. 7,39
- AUTORI: El Mistiri M., Verdecchia A., Rashid I., El Sahli N., El Mangush M., Federico M.
Cancer registration in Northern Africa is still limited and, until now, there have been no population-based data available for Libya. In this paper, we
- Pubblicazione:
- Genes Chromosomes Cancer 45:9-791:797, 2006 - I.F. 5,00
- AUTORI: Agata S., Viel A., Della Puppa L., Cortesi L., Fersini G., Federico M.
The presence of genomic rearrangements of the BRCA1 gene in breast and/or ovarian cancer families has been intensively investigated in patients from various countries
- Pubblicazione:
- BMC Cancer 17:6-210, 2006 - I.F. 4,06
- AUTORI: Cortesi L., Turchetti D., Marchi I., Fracca A., Canossi B., Federico M.
Background: Breast cancer (BC) detection in women with a genetic susceptibility or strong family history is considered mandatory compared with BC screening in the
- Pubblicazione:
- Haematologica 2:7-44:47. 2008 - I.F. 9,94
- AUTORI: Federico M., Bellei M., Pro B., Lopez-Guillermo A., Vitolo U., Luminari S.
not available
- Pubblicazione:
- Annals of Oncology 17:4-676:682, 2006 - I.F. 32,97
- AUTORI: Gobbi PG., Broglia C., Valentino F., Mammi C., Lombardo M., Federico M.
Background: It is still unclear the actual contribute of dose intensity (DI), dose size (DS) and dose density (DD) in the conventional chemotherapy of
- Pubblicazione:
- Hematological Oncology 24-64:72, 2006 - I.F. 5,27
- AUTORI: Luminari S., Federico M.
Follicular lymphoma (FL) is as an indolent neoplasia with median survival measured in decades. Nevertheless, some patients have poor progression-free survival and overall survival.
- Pubblicazione:
- European Journal of Haematology 76:3-217:229, 2006 - I.F. 2,99
- AUTORI: Federico M., Luminari S., Gobbi PG., Sacchi S., Di Renzo N., Brugiatelli M.
Objectives: To compare two different schedules of two different anthracycline-containing regimens, where length of treatment is modulated according to the international prognostic index (IPI)
- Pubblicazione:
- Bone Marrow Transplant 37:3-283:288, 2006 - I.F. 5,48
- AUTORI: Morabito F., Stelitano C., Luminari S., Mammi C., Marcheselli L., Federico M.
GISL recently conducted an exhaustive survey of 1078 patients with Hodgkin’s Lymphoma (HL) enrolled between 1988 and 2002 in different prospective trials. Treatment failure
- Pubblicazione:
- Clincal Cancer Research 12:2-529:535, 2006 - I.F. 12,53
- AUTORI: Paolo G. Gobbi, Chiara Broglia, Alessandro Levis, Antonio La Sala, Francesco Valentino, Massimo Federico
Purpose: MOPPEBVCAD (mechlorethamine, vincristine, procarbazine, prednisone, epidoxirubicin, bleomycin, vinblastine, lomustine, doxorubicin, and vindesine) chemotherapy with limited radiotherapy was devised in 1987 to reduce late
- Pubblicazione:
- BMC Cancer 6-17, 2006 - I.F. 4,06
- AUTORI: Cortesi L., Chiuri VE., Ruscelli S., Bellelli V., Rashid I., Federico M.
Background: The reduced mortality rate from breast carcinoma among women offered screening mammography is demonstrated after 15–20 years of follow-up. However, the assessment of
- Pubblicazione:
- Journal Clinical of Oncology 23:36-9198:9207, 2005 - I.F. 44,54
- AUTORI: Gobbi PG , Levis A , Chisesi T , Broglia C , Vitolo U , Federico M
Purpose In this multicenter, prospective, randomized clinical trial on advanced Hodgkin’s lymphoma (HL), the efficacy and toxicity of two chemotherapy regimens, doxorubicin, vinblastine, mechlorethamine,
- Pubblicazione:
- Histopathology 46-522:531, 2005 - I.F. 5,08
- AUTORI: Rossi G., Valli R., Bertolini F., Marchioni A., Cavazza A., Mucciarini C., Migaldi M., Federico M., Trentini G.P., Sgambato A.
Aims: To investigate the value of platelet-derived growth factor receptors (PDGFRs) by immunohistochemistry in discriminating KIT-negative gastrointestinal stromal tumours (GISTs) from other soft-tissue neoplasms
- Pubblicazione:
- Public Health Nutrition 8:8-1307:1314, 2005 - I.F. 4,02
- AUTORI: Vinceti M., Pellacani G., Malagoli C., Bassissi S., Sieri S., Seidenari S.
Objective: We aimed at examining the association between dietary constituents and risk of cutaneous melanoma. Design: In an area of northern Italy we recruited
- Pubblicazione:
- Journal of Trace Elements in Medicine and Biology 19:1-69:73, 2005 - I.F. 3,84
- AUTORI: Bergomi M., Pellacani G., Vinceti M., Bassissi S., Vivoli R., et al.
Melanoma incidence has been steadily increasing in recent years in most western countries, thus suggesting a role of environmental risk factors. Among these determinants,
- Pubblicazione:
- Journal of Exposure Analysis Environmental Epidemiology 15:5-458:462, 2005 - I.F. 5,56
- AUTORI: Vinceti M, Bassissi S, Malagoli C, Pellacani G, Seidenari S, et al.1
Purpose: Our aim was to examine the risk of melanoma in association with exposure to trace elements of toxicological and nutritional interest. Methods: We
- Pubblicazione:
- Leukemia & Lymphoma 46:2-257:263, 2005 - I.F. 3,28
- AUTORI: Cosenza M, Civallero M, Sacchi S, Marcheselli R, Pozzi S
The efficacy of All-Trans Retinoic Acid (Atra) and Arsenic Trioxide (As2O3) in the treatment of Acute Promyelocytic Leukemia (APL) is well known. Further, these
- Pubblicazione:
- Journal of Cell Science 117(Pt24)-5815:5823, 2004 - I.F. 5,28
- AUTORI: Marconi A., Atzei P., Panza C., Fila C., Tiberio R., Pincelli C.
β1-integrin protects keratinocyte stem cells (KSC) from cell-detachment apoptosis (‘anoikis’). Here we show that caspase-8 active protein is detected in both young transit amplifying
- Pubblicazione:
- Cancer 101:7-1601:1608, 2004 - I.F. 6,10
- AUTORI: Morabito F, Gallamini A, Stelitano C, Callea V, Guglielmi C, Federico M
BACKGROUND. To assess the impact of T-cell/B-cell phenotype on clinical outcome, the authors retrospectively compared patients who had peripheral T-cell lymphoma, unspecified (PTCL-U), with
- Pubblicazione:
- New England Journa of Medicine 351:14-1403:1408, 2004 - I.F. 91,24
- AUTORI: Charles L. Bennett , Stefano Luminari , Allen R. Nissenson , Martin S. Tallman , Stephen A. Klinge , Nicole Casadevall
background Between 1988 and 1998, antibody-associated pure red-cell aplasia was reported in three patients who had undergone treatment with recombinant human erythropoietin (epoetin). Between
- Pubblicazione:
- Leukemia & Lymphoma 44:11-1911:1917, 2003 - I.F. 3,28
- AUTORI: Rigacci L., Federico M., Martelli M., Zinzani P.L., Cavanna L., Bellesi G., Merli F., Alterini R., Petrucci M.T., Tani M., Liberati A.M., Vitolo U., Pavone V., Cuneo A., Chisesi T., Brugiatelli M.
In order to elucidate the role of anthracycline based combination chemotherapy regimens for the treatment of follicular lymphoma we conducted a retrospective study on
- Pubblicazione:
- Journal of Investigative Dermatology 121:6-1515.1521, 2003 - I.F. 8,55
- AUTORI: A Marconi, M Terracina, C Fila, J Franchi, F Bontè, C Pincelli et al
Whereas nerve growth factor has been extensively studied in human keratinocytes, little is known on the role of other members of the neurotrophin family.We
- Pubblicazione:
- Journal of Clinical Oncology 21:12-2320:2325, 2003 - I.F. 44,54
- AUTORI: Massimo Federico, Monica Bellei, Pauline Brice, Maura Brugiatelli, Arnon Nagler, Angelo Michele Carella
Purpose: To determine whether high-dose therapy (HDT) with autologous stem-cell transplantation (ASCT) should be included in the initial consolidative treatment of patients with advanced,
- Pubblicazione:
- Cancer Therapy 1-63:70, 2003
- AUTORI: Federico M., Callea V., Danesi R., Montanini A., Di Renzo N., Petrini M., Del Tacca M., Sirotti M.A., Santacroce G., Bagnulo A., Dell’Olio M., Brugiatelli M., for GISL
Backeround. Taking into account the promising results achieved with purine analogs in combination regimens in patients with indolent NHS, we designed a phase II
- Pubblicazione:
- Leukemia & Lymphoma 43:10-1933:1938, 2002 - I.F. 3,28
- AUTORI: Morabito F., Baldini L., Stelitano C., Luminari S., Frassoldati A., Merli F., Colombi M., Sabbatini R., Brugiatelli M., Federico M.
Only recently both the Revised European American Lymphoma (REAL) and World Health Organization (WHO) classifications clearly identified indolent non-follicular non-Hodgkin’s lymphoma (NHL) as a
- Pubblicazione:
- Cancer Causes and Control 13-729:734, 2002 - I.F. 2,50
- AUTORI: Turchetti D., Mangone L., Negri R., Rossi G., Cortesi L., Vinceti M., Maiorana A., Gallo E., Federico M.:
Objective: Assessing changes in breast cancer (BC) incidence and stage distribution in the District of Modena, Italy, during the period 1992–1998, and their relationship
- Pubblicazione:
- Oncogene 21:27-4328:4334, 2002 - I.F. 9,86
- AUTORI: Saverio Bettuzzi, Francesca Scorcioni, Serenella Astancolle, Pierpaola Davalli, Maurizio Scaltriti, Arnaldo Corti
Clusterin is a highly conserved, widely distributed glycoprotein whose biological significance is still debated. Involved in many biological processes and disease states, clusterin is
- Pubblicazione:
- FEBS Letters 524 (1-3)-139:144, 2002 - I.F. 4,12
- AUTORI: Rossana Tiberio, Alessandra Marconi, Chiara Fila, Cristiana Fumelli, Stan Krajewski, Carlo Pincelli
Because inhibition of integrin signaling induces apoptosis, we investigated whether keratinocytes expressing L1 and K6L4 integrins (enriched for stem cells)are protected from cell death.
- Pubblicazione:
- Journal Clinical of Oncology 20:39-638:646, 2002 - I.F. 44,54
- AUTORI: Massimo Federico, Pier Luigi Zinzani, Antonio Frassoldati, Marco Vinceti, Alessia Modè, Eugenio Damasio
Purpose: The purpose of the present study was to assess the risk of second cancers in patients with hairy cell leukemia (HCL). Patients and
- Pubblicazione:
- Critical Reviews in Oncology Hematology 37-13:25, 2001 - I.F. 6,31
- AUTORI: Sacchi S., Federico M., Dastoli G., Fiorani C., Vinci G., Clò V., Casolari B.
Rituximab is a chimeric anti CD-20 monoclonal antibody containing human IgG1 kappa constant regions, with murine variable regions. The anti-lymphoma effects of Rituximab are
- Pubblicazione:
- Haematologica 86:99-951:958, 2001 - I.F. 9,94
- AUTORI: Stefano Sacchi, Massimo Federico, Umberto Vitolo, Carla Boccomini, Daniele Vallisa, Giuseppe Dastoli
Background and Objectives. To determine the clinical activity and safety of the combination immunotherapy of the chimeric anti-CD20 antibody, rituximab, and interferon (IFN)-α2a. Design
- Pubblicazione:
- European Journal of Cancer 36-2083:2089, 2000 - I.F. 9,16
- AUTORI: Turchetti D., Cortesi L., Federico M., Bertoni C., Mangone L., Ferrari S., Silingardi V.
Breast cancer in young women is uncommon and often presents with unfavourable biopathological features. Although early age at onset could suggest a genetic susceptibility
- Pubblicazione:
- Blood 95:3-783:789, 2000 - I.F. 22,11
- AUTORI: Massimo Federico, Umberto Vitolo, Pier Luigi Zinzani, Teodoro Chisesi, Vera Clò, Luigi Resegotti
Patients (n-987) with a histologically confirmed diagnosis of follicular lymphoma were studied with the aim of developing a prognostic model specifically devised for this
- Pubblicazione:
- Cancer Research 60:1-28:34, 2000 - I.F. 12,70
- AUTORI: Saverio Bettuzzi, Pierpaolo Davalli, Serenella Astancolle, Cesare Carani, Bruno Madeo, Arnaldo Corti
Using Northern blotting, the expression levels of the genes for polyamine metabolism regulatory proteins and clusterin have been measured in a series of 23
- Pubblicazione:
- New England Journal of Medicine (ISSN 0028-4793) 343:19-1378:1385, 2000 - I.F. 91,24
- AUTORI: Mario Luppi, Patrizia Barozzi, Thomas Schulz, Gisella Setti, Katherine Staskus, Giuseppe Torelli
Background Human herpesvirus 8 (HHV-8) infection has been linked to the development of Kaposi’s sarcoma and to rare lymphoproliferative disorders. Methods We used molecular
- Pubblicazione:
- Biochemical and Biophysical Research Communications 257:2-460:465, 1999 - I.F. 3,57
- AUTORI: Maria Giuseppina Monti, Stefania Ghiaroni, Daniela Barbieri, Claudio Franceschi, Gaetano Marverti, Maria Stella Moruzzi
The presence of polyamines is required for the apoptotic program triggered by 2-deoxy-D-ribose (dRib) in HL-60 cells, but their oxidative metabolites does not appear
RICERCA SUL CANCRO
PUBBLICAZIONI SCIENTIFICHE
Tutti i nostri articoli pubblicati sulle riviste scientifiche
VAI
PROGETTI DI RICERCA
I progetti di ricerca che abbiamo sostenuto
VAI
BORSE DI STUDIO E STAGE ALL'ESTERO
Borse di studio e stage all'estero per ricercatori finanziati dall'Associazione
VAI
PREMI DI STUDIO
Stage all'estero per ricercatori sostenuti dall'Associazione
VAI
PREMIO "PIER CAMILLO BECCARIA"
Conferito ogni anno ad un illustre studioso che si è distinto nella lotta contro i tumori
VAI